Shinsato · Journal of cardiology 2010 · randomized controlled trial · n=21

Waon therapy mobilizes CD34+ cells and improves peripheral arterial disease.

Cited 60 times in the scientific literature.

Level 2 - randomized trial

Individual randomized controlled trial

PubMed 20843662 · doi:10.1016/j.jjcc.2010.08.004 · record verified 2026-08-28

What was done

A randomized controlled trial investigated the mechanisms and clinical effects of Waon (far-infrared dry sauna) therapy in 21 consecutive patients with peripheral arterial disease (PAD) receiving standard medications. Participants were randomized to a control group receiving conventional therapy alone (n=10) or a Waon therapy group receiving daily sessions for 6 weeks alongside standard therapy (n=11). At baseline and 6 weeks, investigators measured leg pain scores (visual analogue scale), ankle-brachial pressure index (ABPI), 6-minute walking distance, circulating CD34+ progenitor cell frequency (via quantitative real-time PCR), and serum nitrate/nitrite levels.

What was found

In the Waon therapy group, circulating CD34+ progenitor cell frequency increased significantly from 2.0 ± 1.2 (×10⁻⁴) at baseline to 3.9 ± 1.9 (×10⁻⁴) at 6 weeks (p=0.015), whereas it was unchanged in controls (1.8 ± 1.8 to 1.2 ± 0.9 ×10⁻⁴). Serum nitrate and nitrite levels increased significantly with Waon therapy (29.6 ± 17.6 to 36.0 ± 17.7 μmol/ml, p<0.05) compared to non-significant changes in controls (34.4 ± 9.4 to 38.3 ± 8.8 μmol/ml). Leg pain scores, ABPI, and 6-minute walking distance improved significantly in the Waon group but not in controls; exact numerical values for these functional endpoints were not reported in the abstract.

Why it matters

This study provides mechanistic evidence that thermal therapy may benefit PAD by mobilizing endothelial progenitor cells and increasing nitric oxide metabolites, correlating with functional improvements in limb ischemia.

Limits

The sample size is very small (n=21 total). The abstract omits numerical data and between-group effect sizes for pain, ABPI, and walking distance. Blinding was not feasible, and long-term clinical outcomes such as limb salvage or revascularization were not measured.

Cited by